Literature DB >> 17237550

Embryonic stem cell bank: a work proposal.

A Nieto1, F Cobo, A Barroso-Deljesús, A H Barnie, P Catalina, C M Cabrera, J L Cortes, R M Montes, A Concha.   

Abstract

Human embryonic stem cells (hESCs) have an unlimited capacity to proliferate by a self-renewal process and can be differentiated in the three germ layers, opening doors to new clinical therapies to replace missing or damaged cells. The number of research groups and projects using human stem cells has increased largely in the last 5 yr. The creation of stem cell banks is another important step to support the advance of research in this field. Banks must be operated within the strict regulatory famework of good manufacturing practices and good laboratory practices that assure the highest quality standards and must implement a quality system that complies with international quality systems standards. It may also be appropriate to aim at an accreditation in order to assure correct laboratory practices at all times. Stem cell banks should receive the lines previously derived by other groups and hESCs should be provided for groups that justify their use in a research project previously approved by an ethical committee. The assays generally accepted as typical of hESCs together with the microbiological analysis should be performed in order to assure a consistent, reliable, and safe line for the researchers. In this article, the Andalusian Stem Cell Bank proposes a model of a stem cell banking process in order to create a flow diagram of hESC lines and, following the international initiatives in stem cells research, to achieve the full characterization of cells and a standardization of protocols that would simplify the hESCs culture.

Entities:  

Mesh:

Year:  2006        PMID: 17237550     DOI: 10.1007/s12015-006-0018-7

Source DB:  PubMed          Journal:  Stem Cell Rev        ISSN: 1550-8943            Impact factor:   5.739


  38 in total

1.  Preimplantation human embryos and embryonic stem cells show comparable expression of stage-specific embryonic antigens.

Authors:  J K Henderson; J S Draper; H S Baillie; S Fishel; J A Thomson; H Moore; P W Andrews
Journal:  Stem Cells       Date:  2002       Impact factor: 6.277

Review 2.  The UK Stem Cell Bank: its role as a public research resource centre providing access to well-characterised seed stocks of human stem cell lines.

Authors:  Lyn Healy; Charles Hunt; Lesley Young; Glyn Stacey
Journal:  Adv Drug Deliv Rev       Date:  2005-11-10       Impact factor: 15.470

3.  Gene expression signatures of seven individual human embryonic stem cell lines.

Authors:  Heli Skottman; Milla Mikkola; Karolina Lundin; Cia Olsson; Anne-Marie Strömberg; Timo Tuuri; Timo Otonkoski; Outi Hovatta; Riitta Lahesmaa
Journal:  Stem Cells       Date:  2005-08-04       Impact factor: 6.277

4.  Unique gene expression signature by human embryonic stem cells cultured under serum-free conditions correlates with their enhanced and prolonged growth in an undifferentiated stage.

Authors:  Heli Skottman; Anne-Marie Strömberg; Eija Matilainen; Jose Inzunza; Outi Hovatta; Riitta Lahesmaa
Journal:  Stem Cells       Date:  2005-08-11       Impact factor: 6.277

Review 5.  Embryonic stem cells and cardiomyocyte differentiation: phenotypic and molecular analyses.

Authors:  Hong Wei; Ondrej Juhasz; Jinliang Li; Yelena S Tarasova; Kenneth R Boheler
Journal:  J Cell Mol Med       Date:  2005 Oct-Dec       Impact factor: 5.310

6.  Methods for derivation of human embryonic stem cells.

Authors:  Hee Sun Kim; Sun Kyung Oh; Yong Bin Park; Hee Jin Ahn; Ki Cheong Sung; Moon Joo Kang; Lim Andrew Lee; Chang Suk Suh; Seok Hyun Kim; Dong-Wook Kim; Shin Yong Moon
Journal:  Stem Cells       Date:  2005-07-28       Impact factor: 6.277

Review 7.  Derivation and spontaneous differentiation of human embryonic stem cells.

Authors:  Michal Amit; Joseph Itskovitz-Eldor
Journal:  J Anat       Date:  2002-03       Impact factor: 2.610

8.  Embryonic stem cell lines derived from human blastocysts.

Authors:  J A Thomson; J Itskovitz-Eldor; S S Shapiro; M A Waknitz; J J Swiergiel; V S Marshall; J M Jones
Journal:  Science       Date:  1998-11-06       Impact factor: 47.728

9.  Comparative evaluation of various human feeders for prolonged undifferentiated growth of human embryonic stem cells.

Authors:  Mark Richards; Shawna Tan; Chui-Yee Fong; Arjit Biswas; Woon-Khiong Chan; Ariff Bongso
Journal:  Stem Cells       Date:  2003       Impact factor: 6.277

Review 10.  Microbiological control in stem cell banks: approaches to standardisation.

Authors:  Fernando Cobo; Glyn N Stacey; Charles Hunt; Carmen Cabrera; Ana Nieto; Rosa Montes; José Luis Cortés; Purificación Catalina; Angela Barnie; Angel Concha
Journal:  Appl Microbiol Biotechnol       Date:  2005-10-26       Impact factor: 4.813

View more
  5 in total

1.  Application of methods for viral clearance in stem cell production.

Authors:  Fernando Cobo
Journal:  In Vitro Cell Dev Biol Anim       Date:  2007-10-13       Impact factor: 2.416

Review 2.  Banks, repositories and registries of stem cell lines in Europe: regulatory and ethical aspects.

Authors:  Kristina Hug
Journal:  Stem Cell Rev Rep       Date:  2009-02-10       Impact factor: 5.739

3.  Targeted Disruption of the β2-Microglobulin Gene Minimizes the Immunogenicity of Human Embryonic Stem Cells.

Authors:  Dachun Wang; Yuan Quan; Qing Yan; John E Morales; Rick A Wetsel
Journal:  Stem Cells Transl Med       Date:  2015-08-18       Impact factor: 6.940

4.  An improved technique for chromosomal analysis of human ES and iPS cells.

Authors:  Daniela Moralli; Mohammed Yusuf; Mohammad A Mandegar; Suhail Khoja; Zoia L Monaco; Emanuela V Volpi
Journal:  Stem Cell Rev Rep       Date:  2011-06       Impact factor: 5.739

Review 5.  The use of pluripotent stem cell for personalized cell therapies against neurological disorders.

Authors:  Hye-Yeong Ha; Si-Hyong Jang; Ji-Won Jung
Journal:  J Biomed Biotechnol       Date:  2011-12-13
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.